12th Oct 2020 12:00
(Alliance News) -Â Polarean Imaging PLC on Monday said it has received a research unit order for a 9820 Xenon Polariser system from the University of Texas MD Anderson Cancer Center.
The MD Anderson Cancer Center is a major cancer research and teaching hospital.
The new unit will initiate the center's research programme using hyperpolarised noble gas imaging in oncology, the London-listed medical-imaging technology company said, including assessing lung function as consequence of chemotherapy and radiation therapies and providing guidance for improved radiation treatment planning.
"We are excited to begin our relationship with MD Anderson Cancer Center who have pioneered such a breadth of oncology applications for medical imaging for this patient population, and welcome them to the group of our users researching the use of hyperpolarised 129 Xe in pulmonary function," said Chief Executive Richard Hullihen.
Shares in Polarean were up 21% at 58.90 pence in London on Monday.
By Lucy Heming;Â [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
polarean